Source: Richard Craver, WINSTON-SALEM JOURNAL, 12/18/17


Monday, six styles of Camel Snus became the first Reynolds American Inc. tobacco products to enter the Food and Drug Administration review process for gaining modified-risk status. Reynolds submitted modified-risk tobacco product applications April 3. The FDA has filed modified risk applications for substantive review for 18 Camel Snus styles and the process could take up to a year to complete. 

For more of this story, click here.